Nektar Therapeutics Increase (Decrease) in Employee Related Liabilities
Nektar Therapeutics (NKTR) reported Increase (Decrease) in Employee Related Liabilities of -$6.15 million for the 12-month period ending 2022-12-31, per its 10-K filed 2023-02-28.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities · last filed 2023-02-28
- Nektar Therapeutics increase (decrease) in employee related liabilities for the quarter ending 2022-12-31 was -$14.81M.
- Nektar Therapeutics increase (decrease) in employee related liabilities for the quarter ending 2022-09-30 was -$5.93M, a 240.65% decline year-over-year.
- Nektar Therapeutics increase (decrease) in employee related liabilities for the quarter ending 2022-06-30 was $7.67M, a 48.87% increase year-over-year.
- Nektar Therapeutics increase (decrease) in employee related liabilities for the quarter ending 2022-03-31 was $6.92M, a 22.97% decline year-over-year.
- Nektar Therapeutics increase (decrease) in employee related liabilities for fiscal 2022 was -$6.15M, a 611.47% decline from fiscal 2021.
- Nektar Therapeutics increase (decrease) in employee related liabilities for fiscal 2021 was $1.20M, a 74.39% decline from fiscal 2020.
- Nektar Therapeutics increase (decrease) in employee related liabilities for fiscal 2020 was $4.70M, a 206.99% increase from fiscal 2019.
- Nektar Therapeutics increase (decrease) in employee related liabilities for fiscal 2019 was $1.53M, a 8.60% decline from fiscal 2018.
| Period end | Increase (Decrease) in Employee Related Liabilities 3 month | Increase (Decrease) in Employee Related Liabilities 6 month | Increase (Decrease) in Employee Related Liabilities 9 month | Increase (Decrease) in Employee Related Liabilities 12 month |
|---|---|---|---|---|
| 2022-12-31 | -$14.81M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | -$20.74M derived: sum of 2 quarters · filed 2023-02-28 | -$13.07M derived: sum of 3 quarters · filed 2023-02-28 | -$6.15M 10-K · filed 2023-02-28 |
| 2022-09-30 | -$5.93M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-04 | $1.74M derived: sum of 2 quarters · filed 2022-11-04 | $8.66M 10-Q · filed 2022-11-04 | -$8.49M derived: sum of 4 quarters · filed 2023-02-28 |
| 2022-06-30 | $7.67M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-05 | $14.59M 10-Q · filed 2022-08-05 | -$2.56M derived: sum of 3 quarters · filed 2023-02-28 | $1.66M derived: sum of 4 quarters · filed 2023-02-28 |
| 2022-03-31 | $6.92M 10-Q · filed 2022-05-06 | -$10.23M derived: sum of 2 quarters · filed 2023-02-28 | -$6.01M derived: sum of 3 quarters · filed 2023-02-28 | -$860.00K derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-12-31 | -$17.15M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | -$12.93M derived: sum of 2 quarters · filed 2023-02-28 | -$7.78M derived: sum of 3 quarters · filed 2023-02-28 | $1.20M 10-K · filed 2023-02-28 |
| 2021-09-30 | $4.22M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-04 | $9.37M derived: sum of 2 quarters · filed 2022-11-04 | $18.35M 10-Q · filed 2022-11-04 | $2.57M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-06-30 | $5.15M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-05 | $14.13M 10-Q · filed 2022-08-05 | -$1.65M derived: sum of 3 quarters · filed 2023-02-28 | $6.36M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-03-31 | $8.98M 10-Q · filed 2022-05-06 | -$6.80M derived: sum of 2 quarters · filed 2023-02-28 | $1.21M derived: sum of 3 quarters · filed 2023-02-28 | $3.76M derived: sum of 4 quarters · filed 2023-02-28 |
| 2020-12-31 | -$15.78M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | -$7.77M derived: sum of 2 quarters · filed 2023-02-28 | -$5.22M derived: sum of 3 quarters · filed 2023-02-28 | $4.70M 10-K · filed 2023-02-28 |
| 2020-09-30 | $8.01M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-05 | $10.56M derived: sum of 2 quarters · filed 2021-11-05 | $20.48M 10-Q · filed 2021-11-05 | $8.84M derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-06-30 | $2.55M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-06 | $12.47M 10-Q · filed 2021-08-06 | $835.00K derived: sum of 3 quarters · filed 2022-03-01 | $4.23M derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-03-31 | $9.92M 10-Q · filed 2021-05-07 | -$1.71M derived: sum of 2 quarters · filed 2022-03-01 | $1.68M derived: sum of 3 quarters · filed 2022-03-01 | $3.02M derived: sum of 4 quarters · filed 2022-03-01 |
| 2019-12-31 | -$11.63M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | -$8.24M derived: sum of 2 quarters · filed 2022-03-01 | -$6.90M derived: sum of 3 quarters · filed 2022-03-01 | $1.53M 10-K · filed 2022-03-01 |
| 2019-09-30 | $3.39M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06 | $4.73M derived: sum of 2 quarters · filed 2020-11-06 | $13.16M 10-Q · filed 2020-11-06 | -$4.82M derived: sum of 4 quarters · filed 2021-02-26 |
| 2019-06-30 | $1.34M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-07 | $9.77M 10-Q · filed 2020-08-07 | -$8.21M derived: sum of 3 quarters · filed 2021-02-26 | $730.00K derived: sum of 4 quarters · filed 2021-02-26 |
| 2019-03-31 | $8.43M 10-Q · filed 2020-05-08 | -$9.55M derived: sum of 2 quarters · filed 2021-02-26 | -$609.00K derived: sum of 3 quarters · filed 2021-02-26 | $3.24M derived: sum of 4 quarters · filed 2021-02-26 |
| 2018-12-31 | -$17.98M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-26 | -$9.04M derived: sum of 2 quarters · filed 2021-02-26 | -$5.19M derived: sum of 3 quarters · filed 2021-02-26 | $1.67M 10-K · filed 2021-02-26 |
| 2018-09-30 | $8.94M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | $12.79M derived: sum of 2 quarters · filed 2019-11-07 | $19.66M 10-Q · filed 2019-11-07 | $8.83M derived: sum of 4 quarters · filed 2020-02-28 |
| 2018-06-30 | $3.85M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09 | $10.72M 10-Q · filed 2019-08-09 | -$108.00K derived: sum of 3 quarters · filed 2020-02-28 | $4.63M derived: sum of 4 quarters · filed 2020-02-28 |
| 2018-03-31 | $6.87M 10-Q · filed 2019-05-09 | -$3.96M derived: sum of 2 quarters · filed 2020-02-28 | $784.00K derived: sum of 3 quarters · filed 2020-02-28 | $3.67M derived: sum of 4 quarters · filed 2020-02-28 |
| 2017-12-31 | -$10.82M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-28 | -$6.08M derived: sum of 2 quarters · filed 2020-02-28 | -$3.20M derived: sum of 3 quarters · filed 2020-02-28 | -$10.02M 10-K · filed 2020-02-28 |
| 2017-09-30 | $4.74M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | $7.63M derived: sum of 2 quarters · filed 2018-11-08 | $808.00K 10-Q · filed 2018-11-08 | $3.35M derived: sum of 4 quarters · filed 2019-03-01 |
| 2017-06-30 | $2.88M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | -$3.93M 10-Q · filed 2018-08-09 | -$1.39M derived: sum of 3 quarters · filed 2019-03-01 | $1.88M derived: sum of 4 quarters · filed 2019-03-01 |
| 2017-03-31 | -$6.82M 10-Q · filed 2018-05-10 | -$4.27M derived: sum of 2 quarters · filed 2019-03-01 | -$1.00M derived: sum of 3 quarters · filed 2019-03-01 | $1.42M derived: sum of 4 quarters · filed 2019-03-01 |
| 2016-12-31 | $2.55M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-01 | $5.82M derived: sum of 2 quarters · filed 2019-03-01 | $8.24M derived: sum of 3 quarters · filed 2019-03-01 | $12.28M 10-K · filed 2019-03-01 |
| 2016-09-30 | $3.27M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-08 | $5.69M derived: sum of 2 quarters · filed 2017-11-08 | $9.73M 10-Q · filed 2017-11-08 | $2.93M derived: sum of 4 quarters · filed 2018-03-01 |
| 2016-06-30 | $2.42M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09 | $6.46M 10-Q · filed 2017-08-09 | -$342.00K derived: sum of 3 quarters · filed 2018-03-01 | $1.64M derived: sum of 4 quarters · filed 2018-03-01 |
| 2016-03-31 | $4.05M 10-Q · filed 2017-05-10 | -$2.76M derived: sum of 2 quarters · filed 2018-03-01 | -$780.00K derived: sum of 3 quarters · filed 2018-03-01 | $688.00K derived: sum of 4 quarters · filed 2018-03-01 |
| 2015-12-31 | -$6.81M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-01 | -$4.83M derived: sum of 2 quarters · filed 2018-03-01 | -$3.36M derived: sum of 3 quarters · filed 2018-03-01 | $249.00K 10-K · filed 2018-03-01 |
| 2015-09-30 | $1.98M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-04 | $3.45M derived: sum of 2 quarters · filed 2016-11-04 | $7.06M 10-Q · filed 2016-11-04 | -$948.00K derived: sum of 4 quarters · filed 2017-03-01 |
| 2015-06-30 | $1.47M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-04 | $5.08M 10-Q · filed 2016-08-04 | -$2.93M derived: sum of 3 quarters · filed 2017-03-01 | -$562.00K derived: sum of 4 quarters · filed 2017-03-01 |
| 2015-03-31 | $3.61M 10-Q · filed 2016-05-04 | -$4.40M derived: sum of 2 quarters · filed 2017-03-01 | -$2.03M derived: sum of 3 quarters · filed 2017-03-01 | -$71.00K derived: sum of 4 quarters · filed 2017-03-01 |
| 2014-12-31 | -$8.00M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-01 | -$5.64M derived: sum of 2 quarters · filed 2017-03-01 | -$3.68M derived: sum of 3 quarters · filed 2017-03-01 | -$8.51M 10-K · filed 2017-03-01 |
| 2014-09-30 | $2.37M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-06 | $4.33M derived: sum of 2 quarters · filed 2015-11-06 | -$501.00K 10-Q · filed 2015-11-06 | -$157.00K derived: sum of 4 quarters · filed 2016-02-29 |
| 2014-06-30 | $1.96M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-06 | -$2.87M 10-Q · filed 2015-08-06 | -$2.52M derived: sum of 3 quarters · filed 2016-02-29 | $299.00K derived: sum of 4 quarters · filed 2016-02-29 |
| 2014-03-31 | -$4.83M 10-Q · filed 2015-05-01 | -$4.48M derived: sum of 2 quarters · filed 2016-02-29 | -$1.66M derived: sum of 3 quarters · filed 2016-02-29 | $475.00K derived: sum of 4 quarters · filed 2016-02-29 |
| 2013-12-31 | $344.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | $3.17M derived: sum of 2 quarters · filed 2016-02-29 | $5.30M derived: sum of 3 quarters · filed 2016-02-29 | $5.48M 10-K · filed 2016-02-29 |
| 2013-09-30 | $2.82M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-07 | $4.96M derived: sum of 2 quarters · filed 2014-11-07 | $5.14M 10-Q · filed 2014-11-07 | $1.22M derived: sum of 4 quarters · filed 2015-02-26 |
| 2013-06-30 | $2.13M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-01 | $2.31M 10-Q · filed 2014-08-01 | -$1.60M derived: sum of 3 quarters · filed 2015-02-26 | $568.00K derived: sum of 4 quarters · filed 2015-02-26 |
| 2013-03-31 | $179.00K 10-Q · filed 2014-05-08 | -$3.73M derived: sum of 2 quarters · filed 2015-02-26 | -$1.57M derived: sum of 3 quarters · filed 2015-02-26 | $765.00K derived: sum of 4 quarters · filed 2015-02-26 |
| 2012-12-31 | -$3.91M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-26 | -$1.75M derived: sum of 2 quarters · filed 2015-02-26 | $586.00K derived: sum of 3 quarters · filed 2015-02-26 | -$4.03M 10-K · filed 2015-02-26 |
| 2012-09-30 | $2.17M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-07 | $4.50M derived: sum of 2 quarters · filed 2013-11-07 | -$120.00K 10-Q · filed 2013-11-07 | $927.00K derived: sum of 4 quarters · filed 2014-02-27 |
| 2012-06-30 | $2.33M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-09 | -$2.29M 10-Q · filed 2013-08-09 | -$1.24M derived: sum of 3 quarters · filed 2014-02-27 | $1.08M derived: sum of 4 quarters · filed 2014-02-27 |
| 2012-03-31 | -$4.62M 10-Q · filed 2013-05-09 | -$3.57M derived: sum of 2 quarters · filed 2014-02-27 | -$1.25M derived: sum of 3 quarters · filed 2014-02-27 | $507.00K derived: sum of 4 quarters · filed 2014-02-27 |
| 2011-12-31 | $1.05M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-27 | $3.37M derived: sum of 2 quarters · filed 2014-02-27 | $5.13M derived: sum of 3 quarters · filed 2014-02-27 | $3.56M 10-K · filed 2014-02-27 |
| 2011-09-30 | $2.33M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-09 | $4.08M derived: sum of 2 quarters · filed 2012-11-09 | $2.51M 10-Q · filed 2012-11-09 | $1.21M derived: sum of 4 quarters · filed 2013-03-01 |
| 2011-06-30 | $1.75M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-09 | $183.00K 10-Q · filed 2012-08-09 | -$1.12M derived: sum of 3 quarters · filed 2013-03-01 | $1.53M derived: sum of 4 quarters · filed 2013-03-01 |
| 2011-03-31 | -$1.57M 10-Q · filed 2012-05-04 | -$2.87M derived: sum of 2 quarters · filed 2013-03-01 | -$228.00K derived: sum of 3 quarters · filed 2013-03-01 | $1.98M derived: sum of 4 quarters · filed 2013-03-01 |
| 2010-12-31 | -$1.30M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-01 | $1.34M derived: sum of 2 quarters · filed 2013-03-01 | $3.55M derived: sum of 3 quarters · filed 2013-03-01 | -$800.00K 10-K · filed 2013-03-01 |
| 2010-09-30 | $2.64M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-04 | $4.85M derived: sum of 2 quarters · filed 2011-11-04 | $500.00K 10-Q · filed 2011-11-04 | |
| 2010-06-30 | $2.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2011-08-05 | -$2.14M 10-Q · filed 2011-08-05 | ||
| 2010-03-31 | -$4.35M 10-Q · filed 2011-04-29 | |||
| 2009-12-31 | -$1.52M 10-K · filed 2012-02-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |